Lung Cancer Trial, Recruiting NCT07087080 Sponsor: Hasselt University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07087080
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are having a PET-CT scan at ZOL hospital for a lung nodule and are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People who have not fasted (gone without eating or drinking) for at least 6 hours before the blood sample is taken
  • People who have taken any medication on the morning of the blood sample
  • People whose fasting blood sugar level is higher than 200 mg/dL on the morning of the blood sample
  • People who have been diagnosed with cancer at any point in the last five years
  • People who have received any treatment for cancer at any point in the last five years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Liesbet Mesotten, prof. dr., Ziekenhuis Oost-Limburg

Phone: 003289804034

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hasselt University
Registry
ClinicalTrials.gov
Start date
2 March 2022
Est. completion
1 April 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Fasted glutamate concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov